- Home
- LPSN vs IOBT Comparison
LPSN vs IOBT Comparison
Compare LPSN & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- IOBT
- Stock Information
- Founded
- LPSN 1995
- IOBT 2014
- Country
- LPSN United States
- IOBT Denmark
- Employees
- LPSN N/A
- IOBT N/A
- Industry
- LPSN EDP Services
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- IOBT Health Care
- Exchange
- LPSN Nasdaq
- IOBT Nasdaq
- Market Cap
- LPSN 71.2M
- IOBT 62.6M
- IPO Year
- LPSN 2000
- IOBT 2021
- Fundamental
- Price
- LPSN $0.86
- IOBT $1.00
- Analyst Decision
- LPSN Hold
- IOBT Strong Buy
- Analyst Count
- LPSN 4
- IOBT 3
- Target Price
- LPSN $0.97
- IOBT $9.33
- AVG Volume (30 Days)
- LPSN 728.0K
- IOBT 83.8K
- Earning Date
- LPSN 05-07-2025
- IOBT 05-20-2025
- Dividend Yield
- LPSN N/A
- IOBT N/A
- EPS Growth
- LPSN N/A
- IOBT N/A
- EPS
- LPSN N/A
- IOBT N/A
- Revenue
- LPSN $292,025,000.00
- IOBT N/A
- Revenue This Year
- LPSN N/A
- IOBT N/A
- Revenue Next Year
- LPSN $2.35
- IOBT N/A
- P/E Ratio
- LPSN N/A
- IOBT N/A
- Revenue Growth
- LPSN N/A
- IOBT N/A
- 52 Week Low
- LPSN $0.52
- IOBT $0.66
- 52 Week High
- LPSN $2.08
- IOBT $1.79
- Technical
- Relative Strength Index (RSI)
- LPSN 53.16
- IOBT 52.54
- Support Level
- LPSN $0.77
- IOBT $0.95
- Resistance Level
- LPSN $0.99
- IOBT $1.20
- Average True Range (ATR)
- LPSN 0.06
- IOBT 0.09
- MACD
- LPSN 0.01
- IOBT 0.01
- Stochastic Oscillator
- LPSN 54.89
- IOBT 43.10
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.